The Bioprocess Technology Market is expected to surpass USD 61805.63 Million by 2029 at a CAGR of 15.2% from 2023 to 2029; market is growing increasingly due to infectious diseases and chronic diseases

The bioprocess technology market is expected to grow at a CAGR of 15.2% from 2022 to 2029. It is expected to reach over USD 61805.63 million in 2029 from USD 17296.4 million in 2022.

Luton, Bedfordshire, United Kingdom, March 18, 2023 (GLOBE NEWSWIRE) —

Exactitude Consultancy, the market research and advisory wing of Ameliorate Digital Consultancy Private Limited has completed and published the final copy of the detailed research report on Bioprocess Technology Market.

Bioprocess technology is expected to be in high demand from the pharmaceutical sector due to the increasing incidence of infectious diseases and chronic diseases such as cancer. The overall growth of the market is expected to be driven by advancements in biotechnology and biopharmaceutical industry, increasing R&D expenditure, expansion of vaccine production, and technological advancements. Biopharmaceutical outsourcing has emerged as a profitable strategy to address patients’ unmet medical needs. This has led to a growing number of bioprocess systems with increased process efficiency and throughput. These systems provide benefits in complying with regulatory compliance processes. Many biopharmaceutical companies choose disposable systems. This is to provide cost efficiency and technological advancement through increased processing power and capacity. However, strict regulatory policies and high technology costs hinder the bioprocess technology market.

One of the drivers of the bioprocess technology market is increasing funding for bioprocess technology

Click and get free sample report in minutes:

Growth drivers

Bioprocess technology sales figures are driven by an increasing emphasis on preventive measures as well as alternative medicine for special purposes. Key elements influencing the overall market development include the opening of new production facilities and the expansion of established ones in new markets.

The development of new technologies to solve performance and quality problems associated with the production of bioprocess products has resulted in increased investment over the past five years, leading to significant progress in bioprocess technology.

The preference for bio-based goods made from fossil and biodegradable fuels is changing, opening up new development opportunities.

Key elements influencing market growth include opening of new manufacturing facility.

Key factors influencing the overall market growth include the opening of new manufacturing facilities and the expansion of existing facilities in new regions. The development of new technologies to address the performance and quality challenges associated with the manufacture of bioprocess products has led to increased investment over the past five years, significantly advancing the field of bioprocess technology.

The pharmaceutical industry is expected to see significant demand for bioprocess technology due to the rise in chronic diseases such as infectious diseases and cancer. Biopharmaceutical outsourcing is emerging as a successful way to address patients’ unmet medical needs. This has led to the growth of bioprocess systems with higher throughput and higher process efficiency.

Competitive insight

Some of the notable market players operating in the global bioprocess technology market covered in this report are:

  • Advanced instruments

  • Agilent Technologies, Inc.

  • Becton

  • Dickinson And Company

  • Bio-Rad Laboratories, Inc

  • Hoffmann-La Roche Ltd

  • Gonotec Gmbh

  • Knauer Scientific Devices GmbH

  • Merck KGAA

  • The Sartorius Group

  • Thermo Fisher Scientific, Inc. *The company list is indicative

Latest developments

In October 2022, Thermo Fisher Scientific Inc. launched a large-scale cell culture harvesting solution. This DynaSpin disposable centrifuge system, a centrifuge specifically designed to provide an optimal single-use solution for large-scale cell culture harvesting, to improve and streamline the process by reducing the number of depth filtration cartridges required to complete the harvest process.

June 15, 2022 – Advanced Instruments, a leading manufacturer of scientific and analytical instruments and services for the clinical, biopharmaceutical and food and beverage sectors recently announced that it has expanded its direct sales presence in France to the biopharmaceutical and food and beverage markets through its French subsidiary, Advanced Instruments SAS.

With this expansion, the organization has deployed a local sales and marketing team specialized in bioprocessing, a field application research team, a technical service team, customer support resources and central European warehouse. Advanced Instruments has sold a portfolio of osmometers and cryoscopes for more than 30 years in France through distribution partners, and with a direct presence it will increase its customer engagement and support, demonstrating its commitment to this important market.

Browse all “Bioprocess Technology Market Report, by Product Type (Biological Safety Testing, Cell Counting, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration), Application (Antibiotics, Biosimilars, Recombinant Proteins, Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, Academic Research Institutes, Food and Feed Industry , Contract Research Organization) and Geography – Global Market Share, Trend Analysis and Forecast, 2022-2029” Report and TOC at

Segment overview

The market for bioprocess technology is segmented By product type, Upon applicationand By end user.

By type

Upon application

By end user

  • Antibiotics

  • Biosimilars

  • Recombinant proteins

  • Others

  • Biopharmaceutical companies

  • Contract manufacturing organization

  • Academic research institutes

  • The food and feed industry

  • Contract Research Organization

To learn more about this report, request one free sample

Regional insight

North America, the largest market in 2021 accounted for more revenue generation of worldwide sales and is likely to dominate the market during the estimated period. The growth of the region is attributed to the increasing demand for high-quality biologics, the large presence of several domestic and global market players, and the increasing investments in research and development activities by these market players.

Quantitative analysis

  • Market size, estimates and forecasts from 2023 – 2029

  • Market size and revenue estimates for product up to 2029

  • Market revenue estimates for use up to 2029

  • Market revenue estimates by type up to 2029

  • Regional Market Size and Forecast to 2029

  • The company’s finances

What are the key data covered in this Bioprocess Technology market report?

  • CAGR of the market during the forecast period 2023-2029

  • Detailed information on factors that will drive the Bioprocess Technology market growth over the next six years

  • Precise estimation of the Bioprocess Technology market size and its contribution to the parent market

  • Accurate predictions of upcoming trends and changes in consumer behavior.

  • The growth of the biotechnology industry across North America, Europe, APAC, South America, the Middle East and Africa

  • A thorough analysis of the market’s competitive landscape and detailed information on suppliers

  • Comprehensive details on factors that will challenge the growth of Bioprocess Technology market vendors

To know a further revised 2023 list of market players, request a sample report:

Browse other related research reports from Exactitude Consultancy

Biomedical textile market to register an impressive growth with an astounding CAGR value in the future. Because damaged tissues or organs can be treated with biomedical textiles, the demand for biomedical textiles has increased during the pandemic. This is the product of cutting-edge medical innovations in biomedical textiles.

Market for bioinformatics services To record animal industry growth in 2022-2029 | Top Leading Players – Illumina, Thermo Fisher Scientific. Due to the benefits of using informatics solutions for laboratory protocol generation, data management and analysis, these solutions are expected to be in high demand in the next few years.

Bioinformatics market Expected to witness massive growth with a huge CAGR of 15.4%. Growing bioinformatics applications in drug research and development as well as increased bioinformatics support in the creation of customized drugs and clinical diagnostics are driving the demand for the bioinformatics market.

Market for pain management devices Growth strategies, development prospects, competitive landscape and dynamic innovations by 2029. Pain management industry is driven by an increase in the number of surgical operations.

CONTACT: Irfan Tamboli (Head of Sales) - Exactitudeconsultancy Phone: + 1704 266 3234

Leave a Reply

Scroll to Top
%d bloggers like this: